Zantac Injury Lawyer
Drug manufacturers Boehringer Ingelheim and Sonofi recently halted the production of Zantac, a common heartburn medication used by thousands of patients across the United States. This decision came after the United States Food and Drug Administration (FDA) announced that ranitidine medications, such as Zantac, may contain carcinogenic, or cancer-causing, substances.
While we do encounter carcinogens in our daily lives, the carcinogen present in Zantac can cause serious physical, financial, and emotional harm. If you received a cancer diagnosis after taking Zantac, trust the attorneys at Estey & Bomberger, LLP to help you seek justice.
Why Choose Us
- We understand how difficult a Zantac injury can be. Our San Diego personal injury lawyers will handle each aspect of your case from consultation to settlement, allowing you to focus on recovery instead of complex legal processes.
- Our attorneys have won millions of dollars for our clients. One of our cases, Jane Doe v. U.S. Soccer Association, secured the highest single-person settlement in American history.
- With over 40 years of experience handling defective drug lawsuits, our injury attorneys understand the strategies and skills necessary to combat large corporate legal teams during trial.
Ranitidine and Cancer: What You Need to Know
Zantac is the brand name for ranitidine, which is a medication that helps decrease stomach acid production. Since stomach acid can contribute to unpleasant, albeit common, conditions such as heartburn and acid reflux, Zantac was a very popular over-the-counter medication prior to the FDA announcement.
The FDA discovered that drugs containing ranitidine may also contain a substance called N-nitrosodimethylamine, or NDMA. NDMA contributed to cancer development in animals during laboratory studies, and may also contribute to cancer in humans. In fact, many patients are filing lawsuits against the manufacturers Boehringer Ingelheim and Sonofi for their Zantac-related cancer. The FDA requested that these manufacturers remove all ranitidine products from the market in April 2020.
What Cancers Can Zantac Cause?
Since Zantac litigation is relatively new, it is unclear exactly which cancers this medication may cause. However, NDMA may lead to cancer development in the stomach and bladder areas. Each of these cancers hold different symptoms and result in different survival outcomes.
- Bladder cancer: This cancer has a 96% five-year survival rate if it does not spread from the bladder, and a 5% survival rate if it spreads far from the bladder. Symptoms may include blood in the urine, frequent urination, pain during urination, and lower back pain.
- Liver cancer: This serious condition has a 33% five-year survival rate if the cancer remains local to the liver, and a 2% survival rate if it spreads to distant parts of the body. Symptoms of liver cancer include weight loss, fatigue, an enlarged liver or spleen, bloating, and abdominal pain.
- Stomach cancer: 69% of stomach cancer patients survive five years after diagnosis if the cancer remains local to the stomach, and only 5% of patients survive if the cancer spreads distantly. Patients may experience a loss of appetite, heartburn, blood in their vomit, and dark stool.
- Small intestine cancer: This type of cancer has a higher five-year survival rate than others, with 86% of patients surviving localized intestinal cancer and 42% surviving a more distant spread. Small intestine cancer symptoms may include jaundice, anemia, dark stools, weight loss, and abdominal pain.
- Esophageal cancer: Patients with localized esophageal cancer have a 47% five-year survival rate, while patients whose cancer has spread to other parts of the body only have a 5% survival rate. Like gastrointestinal cancers, patients with esophageal cancer may experience dark stool, blood in their vomit, and abdominal pain. They may also experience difficulty swallowing and chest pain.
- Colorectal cancer: Localized colorectal cancer patients have a 90% five-year survival rate, while only 14% of colorectal cancer patients who experienced a distant spread survive during the same time period. Symptoms of colorectal cancer include sudden changes in bowel habits, rectal bleeding or blood in the stool, and an urge to have a bowel movement that doesn’t go away.
Your Legal Options After Zantac Cancer Development
If you received a cancer diagnosis after taking Zantac for at least one year, you may qualify for litigation against Boehringer Ingelheim and Sonofi. You can file a defective drug lawsuit against these manufacturers in California civil court, recovering monetary damages for the losses you suffered due to cancer.
Common types of damages claimed in Zantac lawsuits include past and future medical expenses, including hospitalizations, surgeries, medications, and therapies. You can also claim funds for lost wages, disability accommodations, and even transportation to and from your medical appointments. You may also receive compensation for the physical and emotional pain and suffering you endured as a result of the cancer.
Who Qualifies for a Zantac Lawsuit?
If you are a former Zantac patient who received a cancer diagnosis after using this medication, you may be eligible for a lawsuit against Boehringer Ingelheim and Sonofi. However, you will need to meet three important criteria to qualify for this litigation.
- First, you must prove you took Zantac or a related ranitidine product. Your medical records can prove your Zantac use if your doctor prescribed the medication. If you purchased Zantac over the counter, you can use receipts to prove your usage.
- Second, you must prove you developed cancer linked to NDMA. While the scientific evidence is still accumulating, stomach and bladder cancers are some of the most common among Zantac plaintiffs.
- Finally, you must show a correlation between your Zantac use and cancer diagnosis. Ideally, you should have taken Zantac for at least a year prior to your diagnosis. You may also qualify for litigation if you took higher doses of Zantac regularly.
Only a San Diego Zantac lawsuit attorney can evaluate your case and determine your eligibility for a Zantac lawsuit. If you developed cancer after taking ranitidine medications, speak to a defective drug attorney at Estey & Bomberger, LLP as soon as possible.
Contact Estey & Bomberger, LLP for Your Zantac Case
If you received a cancer diagnosis after taking Zantac, Estey & Bomberger, LLP can help. Our injury attorneys understand the complexities of dangerous drug lawsuits, and our years of legal experience allowed us to develop the strategies and gather the resources necessary to craft a strong case for your compensation.
We offer free consultations with our Zantac lawsuit attorneys at our San Diego office. Contact us today to schedule your appointment and discuss your legal options.